Nationwide Health Properties, Inc. Reports 2010 First Quarter Results
- Completed $438 Million of Investments through Earnings Release Date
- Raising FFO Guidance on the High End of the Range by $0.08 per Share
- Increased Quarterly Cash Dividend to $0.45 per Share
NEWPORT BEACH, Calif., May 6 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the first quarter ended March 31, 2010. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2010 with the Securities and Exchange Commission.
“We began 2010 with a strong balance sheet and an enviable liquidity position. Leveraging our excellent financial position with improvements in the capital markets and the economy, we acquired during the first quarter seven medical office buildings and made an $80 million loan secured by 26 medical office buildings located in seven states,” commented Douglas M. Pasquale, NHP’s Chairman and Chief Executive Officer. “Subsequent to quarter end, we have completed an additional $58 million of investments bringing the year to date total to $438 million,” Mr. Pasquale added.
FIRST QUARTER 2010 RESULTS OF OPERATIONS
The following table presents selected unaudited financial information for the first quarter ended March 31, 2010 as compared to the same period of 2009:
SELECTED FINANCIAL DATA |
|||||
($ in thousands, except per share amounts) |
|||||
Three Months Ended March 31, |
|||||
2010 |
2009 |
$ Change |
% Change |
||
Revenue |
$ 102,428 |
$ 97,083 |
$ 5,345 |
5.5% |
|
Income from Continuing Operations |
$ 31,217 |
$ 29,428 |
$ 1,789 |
6.1% |
|
Net Income Attributable to NHP Common |
|||||
Stockholders |
$ 31,429 |
$ 49,154 |
$ (17,725) |
-36.1% |
|
Net Income Attributable to NHP Common |
|||||
Stockholders Per Diluted Share |
$ 0.26 |
$ 0.47 |
$ (0.21) |
-44.7% |
|
Diluted FFO |
$ 64,191 |
$ 61,569 |
$ 2,622 |
4.3% |
|
Adjusted Diluted FFO |
$ 64,939 |
$ 61,569 |
$ 3,370 |
5.5% |
|
Diluted FFO Per Share |
$ 0.54 |
$ 0.57 |
$ (0.03) |
-5.3% |
|
Adjusted Diluted FFO Per Share |
$ 0.54 |
$ 0.57 |
$ (0.03) |
-5.3% |
|
Diluted FAD |
$ 64,267 |
$ 61,427 |
$ 2,840 |
4.6% |
|
Adjusted Diluted FAD |
$ 65,015 |
$ 61,427 |
$ 3,588 |
5.8% |
|
Diluted FAD Per Share |
$ 0.54 |
$ 0.57 |
$ (0.03) |
-5.3% |
|
Adjusted Diluted FAD Per Share |
$ 0.54 |
$ 0.57 |
$ (0.03) |
-5.3% |
|
NON-GAAP FINANCIAL MEASURES
Diluted Funds From Operations (“FFO”) and Diluted Funds Available for Distribution (“FAD”) are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of a net gain on re-measurement of equity interest upon acquisition and a gain on debt extinguishment in 2010.
FIRST QUARTER 2010 INVESTMENT ACTIVITY
Pacific Medical Buildings Update
In February of 2010, we acquired the Poway, CA medical office building for $74.0 million including the issuance of 301,599 OP units and a 71% interest in a joint venture which owns a medical office building in Gilbert, AZ for $6.3 million. Additionally, we committed to loan the joint venture $8.8 million of which we have funded $6.8 million.
In March of 2010, we acquired a 65% interest in a joint venture that owns the Mission Viejo, CA medical office building valued at $79.9 million including the assumption of a $48.1 million mortgage loan with a fixed interest rate of 5.5% expiring in 2017 and the issuance of 152,238 OP units; a 69% interest in a joint venture that owns the Orange, CA medical office building valued at $69.3 million including the assumption of a $50.2 million mortgage loan with a fixed interest rate of 5.8% expiring in 2017 and the issuance of 121,489 OP units; the remaining 55.05% interest in two San Bernardino, CA assets that we did not already own with a total value of $17.4 million including the assumption of an $11.2 million mortgage loan with a variable interest rate currently at 3.0% expiring in July 2010; and a 71% interest in a joint venture which owns a medical office building in Pasadena, CA for $13.5 million. Additionally, we committed to loan the Pasadena, CA joint venture $59.5 million of which we have funded $52.8 million.
We have also signed the amended and restated pipeline agreement whereby Pacific Medical Buildings will be responsible for development and NHP will be responsible for project financing for approved development projects. Other modifications to the development agreement provide NHP with improved terms, including preferred returns, a reduced promote interest to PMB and pricing determined at the time of acquisition rather than at the pre-development stage.
Other Investments
We invested approximately $3.7 million in revenue producing capital expenditures at a blended yield of 8.6% on our existing triple-net portfolio and $80.1 million in an 8.25% loan secured by 26 medical office buildings located in seven states.
FIRST QUARTER 2010 FINANCING TRANSACTIONS
During the first quarter of 2010, we issued and sold 1.3 million shares of our common stock through our at-the-market equity offering program at an average price of $35.58 per share, resulting in net proceeds of approximately $44.7 million. From April 1, 2010 to May 6, 2010, we issued and sold 1.6 million shares of our common stock through our at-the-market equity offering program at an average price of $35.08 per share, resulting in net proceeds of approximately $55.2 million.
In the fourth quarter of 2009, we called for redemption our Series B convertible preferred stock. During the first quarter of 2010, shareholders of our Series B convertible preferred stock converted 512,727 shares of Series B preferred stock into 2.3 million shares of our common stock, and we redeemed the remaining 917 shares of our Series B convertible preferred stock.
2010 GUIDANCE
As a result of closed acquisitions and common shares issued through our release date of May 6, 2010, we are increasing by $0.08 per share the high end of the range from $2.09 per share to $2.17 per share and by $0.09 per share the low end of the range from $2.05 per share to $2.14 per share for our full-year 2010 adjusted diluted FFO guidance. We are also increasing by $0.08 per share the high end of the range from $2.05 per share to $2.13 per share and by $0.09 per share the low end of the range from $2.01 per share to $2.10 per share for our full-year 2010 adjusted diluted FAD guidance. Our guidance includes shares issued through our at-the-market equity offering program and closed acquisitions through May 6, 2010 and excludes any other acquisitions, investments, impairments or capital transactions that may occur in the remainder of 2010.
CONFERENCE CALL INFORMATION
We have scheduled a conference call and webcast on Friday, May 7, 2010 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) to discuss these results. The conference call is accessible by dialing 800-299-7098 and referencing conference ID number 32150685 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-801-9715. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) that day until 9:00 p.m. Pacific Time (Midnight Eastern Time) on June 7, 2010. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 46033547. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended March 31, 2010 is available on our website, free of charge, at http://www.nhp-reit.com by selecting “Investor Relations” followed by “Financial Information” and is included in our Current Report on Form 8-K filed May 6, 2010 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.
ABOUT NATIONWIDE HEALTH PROPERTIES, INC.
Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of March 31, 2010, the Company’s portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 606 properties among the following segments: 279 senior housing facilities, 197 skilled nursing facilities, 112 medical office buildings, 11 continuing care retirement communities and 7 specialty hospitals. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.
FORWARD LOOKING STATEMENTS
Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; the effect of healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.
Contact: |
|
Abdo H. Khoury |
|
Chief Financial and Portfolio Officer |
|
Nationwide Health Properties, Inc. |
|
(949) 718-4400 |
|
***Financial Tables to Follow***
NATIONWIDE HEALTH PROPERTIES, INC. |
|||||
CONSOLIDATED INCOME STATEMENTS |
|||||
(In thousands, except per share data) |
|||||
(Unaudited) |
|||||
Three Months Ended March 31, |
|||||
2010 |
2009 |
||||
Revenue: |
|||||
Triple-net lease rent |
$ 74,214 |
$ 74,095 |
|||
Medical office building operating rent |
21,251 |
16,653 |
|||
95,465 |
90,748 |
||||
Interest and other income |
6,963 |
6,335 |
|||
102,428 |
97,083 |
||||
Expenses: |
|||||
Interest expense |
23,590 |
24,071 |
|||
Depreciation and amortization |
31,969 |
30,832 |
|||
General and administrative |
6,984 |
6,931 |
|||
Acquisition costs |
1,443 |
- |
|||
Medical office building operating expenses |
8,647 |
6,834 |
|||
72,633 |
68,668 |
||||
Operating income |
29,795 |
28,415 |
|||
Income from unconsolidated joint ventures |
1,347 |
1,013 |
|||
Gain on debt extinguishment |
75 |
- |
|||
Income from continuing operations |
31,217 |
29,428 |
|||
Discontinued operations: |
|||||
Gains on sale of facilities, net |
22 |
21,152 |
|||
Income from discontinued operations |
- |
53 |
|||
22 |
21,205 |
||||
Net income |
31,239 |
50,633 |
|||
Net loss (income) attributable to noncontrolling interests |
190 |
(27) |
|||
Net income attributable to NHP |
31,429 |
50,606 |
|||
Preferred stock dividends |
- |
(1,452) |
|||
Income available to NHP common stockholders |
$ 31,429 |
$ 49,154 |
|||
Basic earnings per share (EPS): |
|||||
Income from continuing operations attributable to NHP common stockholders |
$ 0.27 |
$ 0.27 |
|||
Discontinued operations attributable to NHP common stockholders |
- |
0.21 |
|||
Net income attributable to NHP common stockholders |
$ 0.27 |
$ 0.48 |
|||
Diluted EPS: |
|||||
Income from continuing operations attributable to NHP common stockholders |
$ 0.26 |
$ 0.27 |
|||
Discontinued operations attributable to NHP common stockholders |
- |
0.20 |
|||
Net income attributable to NHP common stockholders |
$ 0.26 |
$ 0.47 |
|||
Weighted average shares outstanding for EPS: |
|||||
Basic |
117,048 |
102,355 |
|||
Diluted |
119,466 |
104,408 |
|||
NATIONWIDE HEALTH PROPERTIES, INC. |
|||||
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES |
|||||
(In thousands, except per share data) |
|||||
(Unaudited) |
|||||
Reconciliation of Net Income to Adjusted Diluted FFO |
|||||
Three Months Ended March 31, |
|||||
2010 |
2009 |
||||
Net income |
$ 31,239 |
$ 50,633 |
|||
Preferred stock dividends |
- |
(1,452) |
|||
Net loss (income) attributable to noncontrolling interests |
190 |
(27) |
|||
Real estate related depreciation and amortization |
31,545 |
30,808 |
|||
Depreciation in income from unconsolidated joint ventures |
1,239 |
1,307 |
|||
Gains on sale of facilities, net |
(22) |
(21,152) |
|||
FFO available to NHP common stockholders |
64,191 |
60,117 |
|||
Series B preferred dividend add-back |
- |
1,452 |
|||
Diluted FFO |
64,191 |
61,569 |
|||
Acquisition costs |
1,443 |
- |
|||
Gain on extinguishment of debt |
(75) |
- |
|||
Gain on re-measurement of equity interest upon acquisition, net |
(620) |
- |
|||
Adjusted diluted FFO |
$ 64,939 |
$ 61,569 |
|||
Weighted average shares outstanding for diluted FFO: |
|||||
Diluted weighted average shares outstanding (1) |
119,600 |
104,451 |
|||
Series B preferred stock conversion add-back if not already converted |
69 |
3,358 |
|||
Fully diluted weighted average shares outstanding |
119,669 |
107,809 |
|||
Diluted FFO per share |
$ 0.54 |
$ 0.57 |
|||
Adjusted diluted FFO per share |
$ 0.54 |
$ 0.57 |
|||
Dividends declared per common share |
$ 0.44 |
$ 0.44 |
|||
Adjusted diluted FFO payout ratio |
81% |
77% |
|||
Adjusted diluted FFO coverage |
1.23 |
1.30 |
|||
(1) Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis. |
|||||
NATIONWIDE HEALTH PROPERTIES, INC. |
||||||
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES |
||||||
(In thousands, except per share data) |
||||||
(Unaudited) |
||||||
Reconciliation of Net Income to Adjusted Diluted FAD |
||||||
Three Months Ended March 31, |
||||||
2010 |
2009 |
|||||
Net income |
$ 31,239 |
$ 50,633 |
||||
Preferred stock dividends |
- |
(1,452) |
||||
Net loss (income) attributable to noncontrolling interests |
190 |
(27) |
||||
Real estate related depreciation and amortization |
31,545 |
30,808 |
||||
Gains on sale of facilities, net |
(22) |
(21,152) |
||||
Straight-lined rent |
(1,687) |
(1,590) |
||||
Amortization of intangible assets and liabilities |
(59) |
(222) |
||||
Non-cash stock-based compensation expense |
1,594 |
1,573 |
||||
Deferred financing cost amortization |
845 |
814 |
||||
Lease commissions and tenant and capital improvements |
(637) |
(726) |
||||
Unconsolidated joint ventures: |
||||||
Real estate related depreciation and amortization |
1,239 |
1,307 |
||||
Straight-lined rent |
(1) |
(12) |
||||
Deferred finance cost amortization |
21 |
21 |
||||
FAD available to NHP common stockholders |
64,267 |
59,975 |
||||
Series B preferred dividends |
- |
1,452 |
||||
Diluted FAD |
64,267 |
61,427 |
||||
Acquisition costs |
1,443 |
- |
||||
Gain on extinguishment of debt |
(75) |
- |
||||
Gain on re-measurement of equity interest upon acquisition, net |
(620) |
- |
||||
Adjusted diluted FAD |
$ 65,015 |
$ 61,427 |
||||
Weighted average shares outstanding for diluted FAD: |
||||||
Diluted weighted average shares outstanding (1) |
119,600 |
104,451 |
||||
Series B preferred stock add-back if not already converted |
69 |
3,358 |
||||
Fully diluted weighted average shares outstanding |
119,669 |
107,809 |
||||
Diluted FAD per share |
$ 0.54 |
$ 0.57 |
||||
Adjusted diluted FAD per share |
$ 0.54 |
$ 0.57 |
||||
Dividends declared per common share |
$ 0.44 |
$ 0.44 |
||||
Adjusted diluted FAD payout ratio |
81% |
77% |
||||
Adjusted diluted FAD coverage |
1.23 |
1.30 |
||||
(1) Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis. |
||||||
NATIONWIDE HEALTH PROPERTIES, INC. |
||||||
RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES |
||||||
(In thousands, except per share data) |
||||||
2010 Guidance Reconciliation of Net Income to Adjusted Diluted FFO and FAD Per Share |
||||||
Year Ended December 31, 2010 |
||||||
Guidance |
||||||
Low |
High |
|||||
Net income |
$ 142,262 |
$ 145,912 |
||||
Preferred stock dividends |
- |
- |
||||
Real estate related depreciation and amortization |
126,072 |
126,072 |
||||
Depreciation in income from unconsolidated joint ventures |
5,190 |
5,190 |
||||
Net income attributable to noncontrolling interests |
(660) |
(660) |
||||
Gains on sales of facilities, net |
(12,174) |
(12,174) |
||||
FFO available to common stockholders |
260,690 |
264,340 |
||||
Series B preferred dividends |
- |
- |
||||
Diluted FFO |
260,690 |
264,340 |
||||
Acquisition costs |
1,443 |
1,443 |
||||
Gain on extinguishment of debt |
(75) |
(75) |
||||
Gain on re-measurement of equity interest upon acquisition, net |
(620) |
(620) |
||||
Adjusted Diluted FFO |
261,438 |
265,088 |
||||
Straight-lined rent |
(6,984) |
(6,984) |
||||
Amortization of intangible assets and liabilities |
(273) |
(273) |
||||
Non-cash stock-based compensation expense |
6,741 |
6,741 |
||||
Deferred financing cost amortization |
3,149 |
3,149 |
||||
Lease commissions and tenant and capital improvements |
(8,198) |
(8,198) |
||||
Unconsolidated Joint Ventures: |
||||||
Straight-lined rent |
(1) |
(1) |
||||
Deferred financing cost amortization |
84 |
84 |
||||
Adjusted Diluted FAD |
$ 255,956 |
$ 259,606 |
||||
Diluted FFO per share |
$ 2.13 |
$ 2.16 |
||||
Adjusted Diluted FFO per share |
$ 2.14 |
$ 2.17 |
||||
Adjusted Diluted FAD per share |
$ 2.10 |
$ 2.13 |
||||
Weighted average shares outstanding: |
||||||
Diluted weighted average shares outstanding |
120,022 |
120,022 |
||||
NHP/PMB OP units |
2,135 |
2,135 |
||||
Total |
122,157 |
122,157 |
||||
NATIONWIDE HEALTH PROPERTIES, INC. |
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands) |
||||||||
March 31, |
December 31, |
|||||||
2010 |
2009 |
|||||||
(unaudited) |
||||||||
Assets |
||||||||
Investments in real estate: |
||||||||
Land |
$ 317,531 |
$ 318,457 |
||||||
Buildings and improvements |
3,346,489 |
3,088,183 |
||||||
3,664,020 |
3,406,640 |
|||||||
Less accumulated depreciation |
(606,231) |
(585,294) |
||||||
3,057,789 |
2,821,346 |
|||||||
Mortgage loans receivable, net |
197,271 |
110,613 |
||||||
Mortgage loan receivable from related party |
- |
47,500 |
||||||
Investments in unconsolidated joint ventures |
47,797 |
51,924 |
||||||
Net real estate related investments |
3,302,857 |
3,031,383 |
||||||
Cash and cash equivalents |
210,590 |
382,278 |
||||||
Receivables, net |
8,750 |
6,605 |
||||||
Intangible assets |
150,120 |
93,657 |
||||||
Other assets |
141,327 |
133,152 |
||||||
Total assets |
$ 3,813,644 |
$ 3,647,075 |
||||||
Liabilities and Equity |
||||||||
Unsecured senior credit facility |
$ - |
$ - |
||||||
Senior notes |
991,633 |
991,633 |
||||||
Notes and bonds payable |
535,950 |
431,456 |
||||||
Accounts payable and accrued liabilities |
125,244 |
132,915 |
||||||
Total liabilities |
1,652,827 |
1,556,004 |
||||||
Redeemable OP unitholder interests |
77,557 |
57,335 |
||||||
Equity: |
||||||||
NHP stockholders' equity: |
||||||||
Series B convertible preferred stock |
- |
51,364 |
||||||
Common stock |
11,818 |
11,432 |
||||||
Capital in excess of par value |
2,225,737 |
2,128,843 |
||||||
Cumulative net income |
1,736,708 |
1,705,279 |
||||||
Accumulated other comprehensive loss |
(1,385) |
(823) |
||||||
Cumulative dividends |
(1,915,071) |
(1,862,996) |
||||||
Total NHP stockholders' equity |
2,057,807 |
2,033,099 |
||||||
Noncontrolling interests |
25,453 |
637 |
||||||
Total equity |
2,083,260 |
2,033,736 |
||||||
Total liabilities and equity |
$ 3,813,644 |
$ 3,647,075 |
||||||
SOURCE Nationwide Health Properties, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article